



	Questions : Lok Sabha




























Screen Reader Access
Skip to Main Content
Skip to Navigation



Text Size

                                A

                                A
A















हिन्दी मे








Parliament of India Lok Sabha House of the
                        People






* Special Characters not allowed












India Time 


Your Time 


                        Monday,
                        11 April 2022









HomeMembersSitting MembersMembers Home PageMembers' PortalContact DetailsMembers SearchStatistical AnalysisAttendance of MembersHandbook Members Since 1952Digitized Who's WhoOthers BusinessProvisional CalendarList of BusinessPapers to be LaidList of Private Members' BusinessBulletin-IDigitized Lok Sabha Bulletin Part IBulletin-IIStatement of WorkSpecial Mentions (ZERO HOUR)Resume of WorkDigitized Resume of Work done by Lok Sabha QuestionsHomeQuestion ListStatus of notices of questionQuestions CalendarGrouping of Ministries - AlphabeticalOfficers in Min./Dept. Dealing with Parliamentary WorkQuestion SearchSupplementary Questions DebatesIntroductionSynopsisUncorrected DebateText of DebateDigitized DebatesConstituent Assembly DebatesWit And HumourDebate SearchHindi FontsDisclaimer Papers LaidPapers Laid on the Table of the House LegislationIntroduction(How Bill Becomes Act)Bills IntroducedBills PassedBills PendingBills AssentedBills LapsedBills WithdrawnBills NegativedBills Search Disclaimer CommitteesIntroductionChairpersonSummary of WorkCommittee Meetings ScheduleBills Referred to CommitteesReports PresentedDigitized ReportsPress ReleaseMembership SearchToday's Committee MeetingsCommittee Subject SelectedDepartment Related-RS Govt. AssurancesSANSAD TVIntranet





HomeQuestion ListStatus of notices of questionQuestions CalendarGrouping of Ministries - AlphabeticalOfficers in Min./Dept. Dealing with Parliamentary WorkQuestion SearchSupplementary Questions











Download as PDF




Print












PDF/WORD(Hindi)


PDF/WORD




                                    GOVERNMENT OF INDIA
                                





                                    MINISTRY OF
                                    AYURVEDA,YOGA & NATUROPATHY,UNANI,SIDDHA AND HOMEOPATHY (AYUSH)






                                    LOK SABHA
                                





UNSTARRED 


                                    QUESTION NO:
                                

2911






                                    ANSWERED ON: 
                                

12.03.2021






Use of Ayurvedic Products during COVID-19




Bhanu Pratap Singh Verma














                        Will the Minister of





AYURVEDA,YOGA & NATUROPATHY,UNANI,SIDDHA AND HOMEOPATHY (AYUSH)


                        be pleased to state:-















                                                    Will the Minister of AYURVEDA, YOGA AND NATUROPATHY, UNANI, SIDDHA AND HOMOEOPATHY(AYUSH) be pleased to state:(a) whether Ayurvedic products like Giloy have helped to improve the immunity of people during the Corona pandemic thereby reducing the Government and people‘s expenditure on allopathic drugs;(b) if so, the details thereof;(c) whether the Government proposes to increase the production of herbs including Giloy to be used in Ayurvedic drugs in future; and(d) if so, the details thereof and if not, the reasons therefor?






ANSWER




                                                        (a) & (b):	The Ministry of AYUSH has formed an Inter-disciplinary AYUSH R&D Task Force chaired by Prof. Bhushan Patwardhan and having representation from scientists including Indian Council of Medical Research (ICMR), Department of Biotechnology(DBT), Council of Scientific and Industrial Research (CSIR), All India Institute of Medical Sciences (AIIMS) and AYUSH Institutions.  The Interdisciplinary AYUSH Research and Development Task Force has formulated and designed clinical research protocols for prophylactic studies and add-on interventions in COVID-19 positive cases through thorough review and consultative process of experts of high repute from different organizations across the country for studying four different interventions viz. Ashwagandha, Yashtimadhu, Guduchi + Pippali and a poly herbal formulation (AYUSH-64).The task force have taken up the proposals received from screening committees of Councils and proactively explored possibilities based on available leads. Ministry of AYUSH has constituted core group of experts under the Chairmanship of Prof. Bhushan Patwardhan to identify and propose formulations on COVID-19 which are in line with Classical Ayurveda principles and have substantial leads on COVID-19 viz. one for prophylaxis as immunomodulatory, another for management of COVID-19 with antiviral properties and one product for post COVID-19 care.	Ministry of AYUSH has launched interdisciplinary studies involving AYUSH interventions for COVID-19 based on recommendations of Task force. Under various research organizations and National Institutes under Ministry of AYUSH, 112 research studies at 141 centres in the country are being conducted on AYUSH interventions as prophylactic interventions.(c) & (d):	Government has established National Medicinal Plant Board with the objective of  promotion, cultivation and marketing of medicinal plants. Government of India has announced 4000 crore package under Atma Nirbhar Bharat for Promotion of Herbal Cultivation. The Ministry of AYUSH has prepared a scheme namely Pradhan Mantri VRIKSH AYUSH Yojana” for cultivation and marketing of medicinal plants. 	Under ‘Central Sponsored Scheme of Medicinal Plants’ component of National Ayush Mission the government is supporting market driven cultivation of prioritized medicinal plants in identified cluster/zones with in selected districts of States and implemented in a mission mode throughout the country.  As per the scheme guidelines, the support is provided for:(i)	Cultivation of prioritized medicinal plants on farmer’s land.(ii)	Establishment of nurseries with backward linkages for raising and supply of quality planting material.(iii)	Post-harvest management with forward linkages.(iv)	Primary processing, marketing infrastructure etc.	Under this scheme, subsidy @30%, 50% and 75% of cost of its cultivation is provided for cultivation of 140 prioritized medicinal plants on farmer’s land. In the same scheme, Ministry of AYUSH is providing subsidy for cultivation of Giloe on farmer’s land throughout the country @30% of its cultivation cost per hectare i.e. Rs. 48133.31/-. 
























HomeArchiveIndex to Select Questions (1984-1999)Ballot ListStatistical Statements Relating to QuestionsUploading of Questions - Status QueryProcedure for Sending Text of Questions & AnswersDemarcation of responsibilities in Govt. of IndiaBrochure on Statutory Corporations, Companies and Other Bodies in Which the Government of India have financial or controlling interestHighlights pertaining to questions of 17th Lok Sabha






Contact Us 
Disclaimer











        Developed and Hosted by National Informatics Centre (NIC)

Content on this website is published,
            managed & maintained by Software Unit, Computer (HW & SW) Management. Branch,
            Lok Sabha Secretariat





HomeMembersBusinessQuestionsDebatesPapers Laid


LegislationCommitteesSANSAD TVIntranetSecretariatPRIDE


RecruitmentSC/ST ReservationConferenceParliament Library


About ParliamentPhoto GalleryRelated LinksRTITendersFAQ


SpeakerDy. SpeakerLeader of the HousePanel of ChairpersonsContact UsFeedback


Council of MinistersPublications of MinistriesParliamentry ProceduresJournal of Parliamentary Information
Visitor's Counter:113206929







Copyright
Privacy Policy
Disclaimer
Terms &
                Conditions

                Accessibility Statement
Accessibility
                Options
Feedback
Site Map







